Professor of Cell and Molecular Biology, Department of Surgery, The Houston Methodist Research Institute, Weill Cornell Medical College
Tenured Associate Professor, Department of Zoology, the University of Warsaw
Research Associate, Department of Biology, Carleton University in Ottawa
Associate Professor, Department of Biochemistry and Molecular Biology there in 2006.
Distinguished Fellow of the Kosciuszko Foundation in 2014 
Fulbright Senior Specialist Grant Award in 2003
Research Scientist in University of Texas M.D. Anderson Cancer Center in 1987
The MRC Biotechnology Training Award from Dalhousie University in1985
The AHFMR Research Award from the University of Calgary in 1982

Professor of Institute of Genetics and Development of Rennes, Faculty of Medicine, University of Rennes
Director of Dynamics and Mechanics of Epithelia Group, Institute of Genetics and Development of Rennes (IGDR)
Director of National Centre for Scientific Research (CNRS), Faculty of Medicine
Full-time Researcher at the National Centre for Scientific Research (CNRS)

Professor and Head of the Department of Neurology, St. Joseph Hospital Berlin‑Weißensee (Alexianer), Germany, with authorization to train for certification in Neurology (36 months)

Chief Physician (Chefarzt), Clinic for Neurology, St. Joseph Hospital Berlin‑Weißensee, specializing in Multiple Sclerosis and Parkinson’s disease care and research

Recognized as a leading regional and national expert in MS and Parkinson’s disease, based on long-term contributions and clinic development

Awarded the PRIMO MEDICO quality seal (2019 and ongoing), signifying top-tier medical expertise in the German-speaking region

Led the designation of the clinic as a DMSG-certified MS Centre of Excellence (as of October 1, 2019), awarded by the German Multiple Sclerosis Society

Medical Director of GenesisCare Spain, Spain. Interests are Prostate Cancer, Lung Cancer, Adaptive radiotherapy , Next Generation Imaging and Molecular Biomarkers.

Resident (AIOS) - Gastroenterology & Hepatology, Leiden University Medical Centre / HMC in 2019-present
SHO - Transplant Hepatology/General Gastroenterology, Leiden University Medical Centre in 2018
Visiting Scientist - University of Calgary in 2014

• University Distinguished Professor, Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center
• Former Chairman (2012-2024), Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center.
• Fellow, Academy of Toxicological Sciences (ATS)
• Fellow, American Association for the Study of Liver Disease (FASLD)
• President of the Clinical and Translational Specialty Section of SOT (2023-24)
• Translational Impact Award, Society of Toxicology, 2019.

Voluntary Associate Professor, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
Diplomate, Faculty Member, and Advisor, Medical Wellness Association, Houston, TX, USA
Founder and President, Dr. Lewis Nutrition

• Visiting Fellow, Oral and Maxillofacial Surgery / Oral Pathology

Founder,GraphPad Software
Statistics Editor, Molecular Pharmacology
Member Board of Trustees, Cancer Angels of San Diego
Member Board of Trustees, Center for American Culture and Ideas
Member Board of Trustees, Hastings bioethics center
Board Member, New Roads School
Postdoctoral fellow, then Assistant professor, UCSD Pharmacology

Professor (Assistant), School of Community Health SciencesReno, University of Nevada, July 2018 - present
Professor (Assistant), School of Health and KinesiologyStatesboro, Georgia Southern University, August 2014 - June 2018
Ph.D. in Neuroscience, The University of Texas at El Paso, 2014
M.A. in Kinesiology, San Diego State University, 2010

Surgical Resident, Department of SurgeryRotterdam, Erasmus MC, Netherlands

Director and professor, Health Mangement Institute, Chinese PLA General Hospital, Beijing, China

Elsevier's Top 0.5% (2023) and Top 1% (2021-2022) Scientists
Adjunct Professor at the University of Calgary, Calgary, Canada. 
Editor of mBio, an Associate Editor of Virology Journal, etc.
Awards: Hundred-Talent Program of the Chinese Academy of Sciences
Top 25 reviewers for the Journal of Virology (2019, 2020, 2021, 2022)
the Publons Top 1% Peer Reviewers (2019-2020)
Excellent Editors of ASM (mBio), Springer Nature and Frontiers. 

 Director U.O.C. Oncologia, San Giovanni Di Dio Hospital , Italy

Department Head, Mechanical Engineering, Texas A&M University, College Station, Texas, USA
Professor, Mechanical Engineering, Texas A&M University, College Station, Texas, USA
International Society for Optical Engineering (SPIE) Senior Member, 2024
American Institute for Medical and Biological Engineering (AIMBE) Fellow, 2023
American Association for the Advancement of Science (AAAS) Member, 2023
American Society for Engineering Education (ASEE) Member, 2022
Emeritus/Adjunct Professor of Mechanical Engineering UC Riverside, 2021
American Society of Mechanical Engineering (ASME) Fellow, 2020
National Academy of Engineering of Mexico, 2019
STAR Award: Educator of the Year, Society of Hispanic Professionals and Engineers (SHPE), 2014
American Society for Lasers in Medicine and Surgery (ASLMS) Fellow, 2003
Research Scientist Development Award, 2002-2007

Professor, Saitama Medical University

Associate Professor, Medicine-Cardiology, Baylor College of Medicine, Houston, USA
2023 Top Doctor, Houstonia Magazine
Fellow - American College of Cardiology
Fellow - The Society for Cardiovascular Angiography & Interventions (SCAI)

Professor of Clinical Practice, School of Graduate Studies, Lingnan University, Tuen Mun, Hong Kong, China

Professor, Division of Discovery Science, University of Texas Health Science Center, GSBS, Houston, TX
Professor, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX
Co-Director, Department of Center for Environmental and Molecular Carcinogenesis (CEMC), The University of Texas MD Anderson Cancer Center, Smithville, TX, 2012 - 2016
Associate Member, Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX, 2019 - Present
Consultant, Bayer Medical Oncology Division, Houston, Texas, 2002 - 2003
Faculty Member, Center for Molecular Carcinogenesis and Toxicology (CMTC), The University of Texas at Austin, Austin, TX, 2000 - Present
Assistant Biologist, Science Park- Research Division, The University of Texas M.D. Anderson Cancer Center, Smithville, TX, 1987 - 1988
Research Associate, Department of Carcinogenesis, Science Park- Research Division, The University of Texas M.D. Anderson Cancer Center, Smithville, TX, 1985 - 1986
Project Investigator, Science Park- Research Division, The University of Texas MD Anderson Cancer Center, Smithville, TX, 1983 - 1985
Research Fellow, Atomic Energy Commission, Buenos Aires, 1980 - 1983

Institutional Committee Activities
Member, Research Integrity Matter MDA 2023-11 Inquiry Committee, 2024 - Present
Judge, Oral Skills Presentation competition for GSBS Student Research Day (GSRD), 2019
Member, MDACC, DCIS Tissue Utilization Committee, 2018
Basic Committee Reviewer, MDACC, Institutional Research Grant (IRG) Committee, 2017 - Present
Member, MDACC, Multidisciplinary Research Advisory Committee (MRAC), 2016 - 2023
Member, MDACC, Institutional Biosafety Committee, 2011 - 2015
Member, Department of Epigenetics and Molecular Carcinogenesis, ARFAC Committee, 2010
Representative, Department of Molecular Carcinogenesis, Faculty Senate Department, 2010 - 2012
Member, GSBS Molecular Carcinogenesis Program, Steering Committee, 2010 - 2011
Member, GSBS Molecular Carcinogenesis Program, Academic Affairs Committee, 2010 - 2014
Member, GSBS Molecular Carcinogenesis Program, Student Admissions Committee, 2010 - 2013
Member, Department of Molecular Carcinogenesis, Hogg Seminar Series Committee, 2006 - 2012
Member, Department of Epigenetics and Molecular Carcinogenesis, Information Resources Advisory Committee, 2005
Member, Department of Molecular Carcinogenesis, Seminar Committee, 2003 - 2006
Member, Department of Epigenetics and Molecular Carcinogenesis, Tenure & Promotions Committee, 2001
Member, Department of Molecular Carcinogenesis, Library Committee, 1999 - 2010
Member, Department of Molecular Carcinogenesis, Cancer Genomics Committee, 1999
Member, GSBS Molecular Carcinogenesis Program, Admissions Committee, 1999 - 2002
Member, Department of Epigenetics and Molecular Carcinogenesis, Shared Resources Committee, 1998
Member, Department of Molecular Carcinogenesis, IACUC Committee, 1992 - 2005
Member, Department of Molecular Carcinogenesis, Faculty Search Committee, 1990 - 1994
Member, Department of Molecular Carcinogenesis, Graduate Education Committee, 1990 - 1999
Member, Department of Epigenetics and Molecular Carcinogenesis, Various Faculty Search Committees, 1989
Member, Department of Molecular Carcinogenesis, Postdoctoral Training Grant Committee, 1988 - 2001

Professor at University of Aveiro, Aveiro, Portugal

Assistant Professor, Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
Co-Chair, 2024 Translational Molecular Pathology Department Retreat, 2024 - 2024
Co-Chair, Translational Molecular Pathology Think Tank Seminar Series, 2022 - Present
Reviewer, Academic Review Committee, 2020 - Present
Co-Chair, Experimental Therapeutics Postdoctoral Seminars, 2017 - 2018
Honors & Awards
2019 The Thomas H. and Mayme P. Scott Fellowship in Cancer Research The Thomas H. and Mayme P. Scott Foundation, Inc, The Thomas H. and Mayme P. Scott Foundation, Inc
2018 AAAS/Science Program for Excellence, AAAS Science
2018 The Diane Denson Tobola Fellowship in Ovarian Cancer Research, The Diane Denson Tobola
2017 The Thomas H. and Mayme P. Scott Fellowship in Cancer Research, The Thomas H. and Mayme P. Scott Foundation, Inc
2015 Award in Translational/Clinical Research, Agilent
2014 Award in Translational Research, The Bayer HealthCare Pharmaceuticals, Inc
2012 AACR Scholar-In-Training Award, Susan G. Komen for the Cure

Dr. Irami Araújo Filho currently holds the position of Associate Professor II in the Discipline of Operative Technique within the Department of Surgery at the Federal University of Rio Grande do Norte. He is a Full Member of the Brazilian College of Surgeons and serves as Master of the Chapter of the Brazilian College of Surgeons in Rio Grande do Norte. Additionally, he is a Full Member of the Brazilian College of Digestive Surgery, a Member of the Pan American Trauma Society, and a Full Member of the Brazilian Society for the Development of Surgical Research.

He holds the role of Deputy Coordinator of the Research Base on Experimental Surgery at Clóvis Sarinho Teaching, Research Manager at Onofre Lopes University Hospital (HUOL), Federal University of Rio Grande do Norte, which is managed by the Brazilian Hospital Services Company - EBSERH. Dr. Araújo Filho is also a Preceptor of the HUOL General Surgery Medical Residency and Vice-President of the Regional of Rio Grande do Norte of the Brazilian Society for the Development of Surgical Research.

He serves as an Effective Professor in the Postgraduate Program in Biotechnology at Potiguar University and as an Effective Professor in the Graduate Program in Management and Technological Innovation in Health at UFRN/EBSERH.

Dr. Araújo Filho's professional experience spans various fields within Medicine, with a focus on General Surgery, Gastroenterology, and Oncology. His research interests include infection in surgery, intercurrent factors in wound healing, radionuclide biodistribution, and experimental models of osteoporosis.

Associate Professor, Faculty of Science, Biophotonics and Medical Imaging
Associate Professor, LaserLaB - Biophotonics and Microscopy

Professor, Federal University of Mato Grosso
Professor, Universidade Nove de Julho

Associate Professor of internal medicine, family medicine, and public health at Charles R. Drew University of Medicine and Science. 
Faculty Member with University of Michigan Psychiatry and UCLA Psychology.
With 20 years of research experience in public health, have published 500 peer-review manuscripts in journals archived by PubMed. Have served on the board of directors of the American College of Epidemiology (ACE) and American Academy of Health Behavior (AAHB). Was the past president of the Scientific Association for Public Health in Iran (SAPHIR).

Neurologist MD, MSc, PhD
Academic Scholar, Aristotle University of Thessaloniki

Adjunct Professor, Department of Psychiatry
Associate Chief of Staff Research and Development, VA Puget Sound

Professor, Departments of Pharmacology and Family & Preventive Medicine
PharmD, Purdue University
MBA, DePaul University
NHA, George Washington University

Associate Professor, Centre for Molecular Medicine and Biobanking, Allied Research Unit, Biomedical Building, University Of Malta

Research Scientist within the Center for Predictive Medicine at the University of Louisville

Professor (Assistant),  University of Bologna

Professor of Physiology Principal Investigator at Université de Poitiers- CNRS

Assistant Professor of the Department of Microbiology, Shahr-e-Qods Branch, Islamic Azad University

Roy G. Beran is trained as a consultant neurologist and accredited sleep physician, in addition to working within legal medicine, military medicine and aviation medicine.  His qualifications include: MBBS, MD, FRACP, FRACGP, Grad. Dip. Tertiary Ed., Grad. Dip. Further Ed., FAFPHM, FACLM, FRCP, FAAN, FACBS, B Leg. S, MHL and FFFLM (Hon). His Orcid ID is 0000-0002-5884-0606. He is registered with the Australian Health Practitioner Regulation Agency (AHPRA) as a specialist in Neurology, Public Health and Sleep Medicine and was a Designated Medical Examiner for the Civil Aviation Safety Authority, a medical assessor for Dispute Resolution for the State Insurance Regulatory Authority and an assessor for the Workers Compensation Commission of New South Wales (NSW). He is a Conjoint Professor of Medicine at the University of NSW; Professor in the School of Medicine at Griffith University, Queensland; and Professor, Chair, Medical Law, Sechenov Moscow 1st State University, Moscow, Russia.  Following Russia’s invasion of Ukraine, he refused to re-sign the agreement with Sechenov University. He was the inaugural Visiting Professor at the International Research Institute of Health Law Sciences at the Southern Medical University, Guangzhou, Guangdong Province, China. In 2022, he was appointed as a Conjoint Professor in the School of Medicine at the Western Sydney University, in addition to the above appointments.

Chief Executive Officer of Hôpitaux Robert Schuman

ESICM Basic Science Award, European Society for Intensive Care Medicine in 2012
Best Abstract Award, StO2 Shock Conference in 2009

Associate Professor, CCA - Cancer biology and immunology
Associate Professor, CCA - Imaging and biomarkers
Associate Professor, Center of Experimental and Molecular Medicine

Professor, Department of Physical Education and Aging Science, Universidade Sao Judas Tadeu, SP, Brazil

Professor, Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Director of the institute
Medical Specialist in Clinical Pharmacology
Medical Specialist in Pharmacology and Toxicology

Neuroradiologist

SB is Full Professor in Bioinorganic Chemistry at Leiden University. He obtained his PhD in 2005 at the University of Strasbourg, France, in the group of Nobel Laureate Jean-Pierre Sauvage, and moved to The Netherlands as a postdoc, where he successively worked in the groups of Gerard van Koten (Utrecht), Jan Reedijk (Leiden), and Antoinette Killian and Bert Klein Gebbink (Utrecht). Between 2009 and 2014 he completed a Tenure Track position in Inorganic Chemistry at Leiden University, where he was tenured in 2015. He obtained several prestigious grants, including a Starting Grant from the European Research Council (2013), and three young investigator grants (VENI 2008, VIDI 2012, VICI 2019) from the Dutch Organisation for Scientific Research (NWO). Since 2015 he is Fellow of the Young Academy of Europe, and in 2017 he became YAE Board Member. His expertise lies at the crossing point between bioinorganic chemistry, photochemistry, and lipid membranes. His current research interests are anticancer photoactivated chemotherapy, supramolecular photocatalysis, and upconversion.

Associate Professor of Gene Therapy, Tytgat Institute, AMC,Amsterdam

Degree in medicine and surgery at the University of Bologna (Italy), specialist license in General Surgery at the University of Modena (Italy) and in Implantology at the University of Sao Paulo (Brazil), Odont. Dr. (PhD) at Göteborg University (Sweden) with Prof. Jan Lindhe & Prof. Tord Berglundh.
Director of “Ariminum Research & Dental Education Center (ARDEC)” in Rimini, (Italy) and Head of the division of Oral Surgery at “ARDEC” (Ariminum Odontologica), Rimini (Italy).
Professor in the post-graduate course, University of the State of São Paulo (UNESP), Faculty of Araçatuba (Brazil). Invited professor at the University of Medical Science of Havana (Cuba) and at Valencia University (Spain).
Member of the Editorial Board of the Journal of Clinical Periodontology and of Clinical Oral Implants Research. He has published about 90 scientific articles on experimental and clinical studies in international scientific journals. He has held more than 400 lectures in courses and congresses in Italy, Europe, USA, South America, Asia, Africa.
His main fields of interest in research are healing of hard and soft tissues around implants and healing at implants installed in compromised sites.
He actively collaborates with Prof. Niklaus Lang in several clinical and experimental studies.
He collaborates in research with several universities.

Professor of Neurology, Chairman of the Department of Neurology, Faculty of Medicine, Masaryk University and St. Anne´s University Hospital, Brno, Czech Republic
Director of Brno Epilepsy Center
Research Group Leader of the Behavioral and Social Neuroscience Research Group CEITEC MU

Senior Medical Director, Clinical Development, Vertex Cell and Gene Therapies at Vertex Pharmaceuticals

1987 - Present : The First Affiliated Hospital, Nanjing Medical University ; 
1999 - Present : International Centre for Allergy Research, Nanjing Medical University  

Chief, The Six Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University

The Chief-Spine-Surgeon, Professor, Vice-president at the Affiliated Rehabilitation Hospital of Nanchang University, the Distinguished Professor of Orthopedics at the First Affiliated Hospital of Nanchang University, China. Serving as Asia Pacific Spine Society (APSS) Board Member, Scoliosis Research Society (SRS) Active Member, Cervical Spine Research Society (CSRS) Corresponding Member and Cervical Spine Research Society-Asia Pacific Section Active Member. Awarded for 2014 SRS GOP Fellowship (New York University Langone Medical Center, Johns Hopkins Hospital), 2015 CAOS-NASS Traveling Fellowship (UCSF, New York-Presbyterian Spine Hospital Columbia University Medical Center, MD Anderson Cancer Center), 2017 APSS Traveling Fellowship(National University Hospital of Singapore, Seoul St. Mary's Hospital Catholic University of Korea, Ganga Hospital of India), 2018 SRS Traveling Fellowship(Hospital for Special Surgery, New York-Presbyterian Spine Hospital Columbia University Medical Center, Washington University in St. Louis, TSRH, San Diego Rady Children's Hospital, Scripps Spine Center, San Diego Spine Foundation) and AO Spine Global Spine Diploma. Published more than 90 peer-reviewed papers focusing on Complex Spine Deformity, Osteoporosis, Cervical Spine, Spine TB.
Clinical services：Scoliosis, Kyphosis, Minimal invasive spine surgery, Spinal stenosis, Herniation, Ankylosing spondylitis, Spondylolysis, Spondylolisthesis, Cervical spine disorders, Cervical radiculopathy, Cervical myelopathy, Spine and spinal cord tumors, Spinal fractures, Revision spine surgery, Spinal osteoporosis,Degenerative spine disease, Spine tuberculosis, Spine trauma, Spine infection.

Dr. E. Carlos Rodriguez-Merchan is a highly accomplished consultant orthopedic surgeon currently working at Hospital Universitario La Paz in Madrid, Spain. With over three decades of experience in the field, Dr. E. Carlos Rodriguez-Merchan has established himself as a leading expert in orthopaedic surgery. He obtained his MD and PhD in orthopedic surgery from Hospital Universitario La Paz and has been actively practicing since 1990. Dr. E. Carlos Rodriguez-Merchan is renowned for his exceptional skills and expertise in performing various orthopaedic procedures. He has made significant contributions to the field through his research and publications.

Joaquim Carreras, MD, PhD. is a pathologist with a medical degree from the University of Barcelona, Spain. His medical specialty was pathology (specialty residency) at the Department of Pathology, Hospital Clinic of Barcelona, Spain. His Ph.D. focused on hematopathology and was obtained from the Department of Pathology, Faculty of Medicine, University of Barcelona. He has worked as a pathologist in Spain, as a clinical research associate at the University of Cambridge (United Kingdom), Biomedical Research Institute of the National Institute of Advanced Industrial Science and Technology (AIST) as a Japan Society for the Promotion of Science (JSPS) post-doctoral fellow, and he is currently at Tokai University School of Medicine.

Associate Professor of Surgery, University of Bologna
Chief General and Emergency Surgery, Bufalini Hospital AUSL Romagna, Italy

Associate Professor of Physiology (M.D., Ph.D.) at the Department of Biomedical and NeuroMotor Sciences of the University of Bologna, Italy.
My research focuses on hibernation and on methods to induce a state resembling hibernation in non-hibernators, including humans.
Currently consulting for the European Space Agency and for the Italian Space Agency.
Member of the National Institute for Nuclear Physics
Member of the Italian Institute of Technology

Dr. William Cho is a biomedical scientist at the Department of Clinical Oncology, Queen Elizabeth Hospital in Hong Kong. With a strong background in cancer biomarker discovery and translational research, Dr. Cho has published extensively in peer-reviewed journals. His research interests include genomics, proteomics, and liquid biopsy in oncology. He actively serves on editorial boards and is a frequent reviewer for international scientific journals.

Dean of the Faculty of Dentistry at the University of Otago in New Zealand. Paul was appointed the John Arnaud Bell Professor of Oral Biology in 2019 at the University of Otago and previously, he worked at the School of Dentistry, University of Birmingham, UK (2000-2019), where he was the Director of Research and Deputy Head of School. Paul has published over 180 full peer-reviewed papers in several areas of dental research with particular interest in pulp biology. In 2010, Paul was awarded the IADR Distinguished Scientist Young Investigator Award. He is currently the President of the Pulp Biology and Regeneration Group of IADR and has also served as the Mineralized Tissue Group (MINTIG) Chair for the British Society for Oral and Dental Research (BSODR) and as a counselor on the BSODR Management Committee.

Assistant Professor, Emergency Medicine, Università Cattolica del Sacro Cuore, Rome, Italy

Research Assistant, Department of Pathology, Medical University of South Carolina (1990)

·  Teaching of Emergency Medicine (2009 – 2015) medical specialization schools: Allergologia ed Immunologia Clinica – Dermatologia e Venereologia – Ematologia – Endocrinologia e malattie del ricambio – Gastroenterologia – Geriatria – Malattie dell’apparato Cardiovascolare – Malattie dell’apparato respiratorio – Malattie infettive – Malattie Tropicali – Medicina interna – Neurofisiopatologia – Neurologia – Oncologia – Psichiatria – Reumatologia - Catholic University of the Sacred Heart - Rome
·   Teaching of Emergency Medicine 2012 – present: School of Specialization in Emergency Medicine  Catholic University of the Sacred Heart - Rome
·   Teaching of Emergency Medicine and First Aid response 2012 – Present: School of specialization in Sport Medicine and School of Internal Medicine - Catholic University of the Sacred Heart – Rome
·   Assistant Professor – Emergency Medicine - Catholic University of the Sacred Heart – Rome 2020 - Present
·   Author of 111 papers published on peer-reviewed journals from 1993 to present (H-index Scopus 23)
·   Author of more than 300 Abstracts presented in National and International Meetings.
·   Member of Italian Society of Emergency Medicine (SIMEU)
·   Member of Italian Society of Internal Medicine (SIMI)Assistant Professor, Emergency Medicine, Università Cattolica del Sacro Cuore, Rome, Italy

Linda Cox, MD, FAAAAI is an allergist in solo private practice in Ft Lauderdale and a clinical associate professor of medicine at Nova Southeastern University. She is a member of the American Academy of Allergy Asthma & Immunology’s (AAAAI) board of directors, and begin her term as AAAAI President on February 25, 2013.

She is past chair of many committees including the AAAAI Immunotherapy, Allergen Standardization and Allergy Diagnostics Committee (IT/AD/ST) and the Immunotherapy, Rhinitis, Sinusitis, Ocular diseases & Cough Interest Section. She has chaired several AAAAI/ACAAI joint task forces including the Sublingual Immunotherapy Joint Task Force, Specific-IgE test Task Force (SETTaF), and the Omalizumab Joint Task Force.

Since 2006, Dr. Cox has been a member of the Joint Task Force on Practice Parameters (JTPP), and was one of the chief editors of the 2^nd and 3^rd updates of the Allergen Immunotherapy: A Practice Parameter.  She has promoted standardization of allergy skin testing and allergen immunotherapy practice through work of the JTFPP and IT/AD/ST. which resulted in the development of standardized immunotherapy, skin test, instruction and consent forms, available at www.aaaai.org.  

Through the World Allergy Organization (WAO), she assisted in the development of a uniform grading system for subcutaneous immunotherapy systemic reactions. She is current co-chair of the WAO Immunotherapy and Immunomodulator Committee.

Dr. Cox is a member of the American Board of Allergy and Immunology Board of Directors, and serves on several of its committees including the Maintenance of Certification and Conjoint Standards committees. She is a past president of the Broward County Medical Association and the Florida Allergy, Asthma & Immunology Society. She was a member of the Florida Medical Association Board of Governors. She has been a member of the BCMA Board of Directors since 1995 She has served as a BCMA delegate almost since almost every year since joining the BCMA and is immediate past chair of the South Florida Caucus Advisory Council.

Dr. Cox attended medical school at Northwestern University in Chicago and completed her fellowship in allergy and immunology at National Jewish Center in Colorado.

Awards/Honors

Dr. Cox has been honored nationally with many awards including: the 2012 AAAAI Women’s Involvement Special Recognition Award; the AAAAI President’s Award for Outstanding Leadership (as Chair of the Immunotherapy and Allergy Diagnostics Committee); an ACAAI Distinguished Service Award and the ACAAI Woman in Allergy Award. Regionally, she received and the Florida Academy of Physician Assistants 2010 Physician Recognition Award.

Dr Undurti N Das, MD, DSc, FAMS, FRSC Prof. Undurti N Das is a physician/scientist based both in the USA and India. His clinical interests include internal medicine with an emphasis on diabetology, endocrinology, rheumatology, and cancer. His research interests include polyunsaturated fatty acids, cytokines, free radicals, and their role in various diseases. Dr. Das is an M.D. in Internal Medicine from India, a DSc in biotechnology, a fellow of the National Academy of Medical Sciences (New Delhi), and a Fellow of the Royal Society of Chemistry, London. He is the recipient of the Shanti Swaroop Bhatnanagr prize in Medical Sciences, the highest scientific award in India. He has published more than 500 original research papers, authored four books, and currently is the Founding Editor of the Lipids in Health and Disease journal by BioMed Central, UK; Review Editor of Nutrition by Elsevier; and Academic Editor of Medicine. He is the President and CEO of UND Life Sciences of USA and Professor and Director of the BioScience Research Centre and Department of Medicine, GVP Medical College and Hospital, Visakhapatnam.

Professional positions
1977-1980: Doctoral student Laboratory for Biochemistry KU Leuven (G.Préaux)
1981-1985: Postdoc Center for Thrombosis and Vascular Research KU Leuven (M. Verstraete, J. Vermylen)
1985-1987: Postdoc Hematology-Oncology, Washington U, School Medicine,St.Louis Mo (P.W. Majerus),
1988-1992: Senior Researcher Center for Molecular & Vascular Biology KU Leuven (D. Collen, J. Vermylen)
1992-1996: Associate Professor in Chemistry KU Leuven Kulak
1994-present: Head of the Laboratory for Thrombosis Research, IRC, KU Leuven Kulak
1996-1999: Professor in Chemistry KU Leuven Kulak
1999-present: Full Professor in Chemistry KU Leuven Kulak
Other
1992-1998: Associate Editor "Thrombosis and Haemostasis".
1994-1998: Editorial Advisor "The Biochemical Journal".
96-02,08-09: Member Research Council KU Leuven
1997 Visiting professor “Pro Renovanda” University of Debrecen, Hongarije, Medical School
1998-2004: Editor "The Biochemical Journal".
1999-2002: Member Advisory Board " Thrombosis and Haemostasis".
2000-6, 9-10: Chairman Interdisciplinary Research Center (IRC), KU Leuven Kulak
2000-2006 Member Board ‘Innovation & Incubation Center Kortrijk’ (IICK)
2002-present Member Advisory Board " Journal of Thrombosis and Haemostasis".
2002-present Member Board & webmaster ‘Belgian Society on Thrombosis and Haemostasis’ (BSTH)
2004-present Spokesman “Interfacultary Center for Biomacromolecular Structure Research” (BioMacS) KU Leuven 
2005-2007 Member Council for Industrial Research KU Leuven
2006-2008 Section Editor ‘Thrombosis and Haemostasis’
2006-2010 Member FWO commission Molecular & Cellular Biology, Genetics
2007-present Executive Officer & webmaster ‘European Thrombosis Research Organisation’ (ETRO)
2007-present Founding member and spokesman PharmAbs http://www.pharmabs.org/
2010-present Research coordinator KU Leuven Kulak
2010-2012 Chairman FWO commission Molecular & Cellular Biology, Genetics
2011-present Program director POC Cluster BioChem Kulak

Honors and awards
1978-1979: Fellowship IWONL (Institute for Advancement of Sc.Res. in Industry & Agriculture, Belgium)
1985: Prize Boehringer-Ingelheim for Research on Thrombosis and Coagulation
1985-1987: NATO Research Fellowship
1985-1986: Fulbright Research Award
1989: Young Investigator Award XIIth Congress on Thrombosis and Haemostasis
1991 Prize "Dr. en Mevr. Schamelhout-Koettlitz "-Foundation for Scientific Research (Royal Academy of Medicine of Belgium)
1992 Fellowship "Belgian Action against Cancer"
1993 Triannual Prize Baron Simonart Foundation for Clinical Pharmacological Research
1995 Research grant O.Dupont Foundation (Royal Academy of Medicine of Belgium)
2004 Triannual price Sidmar for ‘Medical Scientific Research’ (Royal Academy for Medicine)
2009 Doctor Honoris Causa, University of Debrecen, Hungary

Memberships, meetings, journals
1. International Society on Thrombosis and Haemostasis (ISTH)
1992-present: Member
1992-8: Associate Editor Journal of the Society: "Thrombosis and Haemostasis"
1999-2001: Member Advisory Board " Thrombosis and Haemostasis".
2002-present: Member Advisory Board " Journal on Thrombosis and Haemostasis".
2. Biochemical Society
1994-2006: member
1994-1998: Editorial Advisor of "The Biochemical Journal"
1998-2003: Co-Editor of "The Biochemical Journal"
3. European Thrombosis Research Organisation (ETRO)
1995-present: Laboratory for Thrombosis Research, IRC-KULAK elected member 2007-10: Executive Officer & webmaster
4. Belgian Society on Thrombosis and Haemostasis (BSTH)
1993-present member
2002-present member of the board & webmaster
Member Scientific Committee European Platelet and Granulocyte Immunobiology Symposium (Bamberg, DE 1992, Cambridge, UK 1994, Hammeenlinna, SF 1996, S'Agaro, SP, 1998, Amsterdam,NL, 2000, Lago Maggiore, IT, 2002, Rust AT, 2004, Tromso, NO, 2006, Thun, CH, 2008, Beaune, FR 2010, Warsaw, PL 2012)

Teaching
1992-present: General Chemistry: 1st yr Medicine, Biomedical Sciences, Biochemistry, Biology, Chemistry, Physics, Mathematics, Bio-engineers, Pharmacy
1992-2003: Chemistry II (Systematics): 1st yr Biochemistry, Chemistry, Biology
1996-2000: Mechanisms of signal transduction: PhD-training Sci-Bioengin-Pharmacy-Biomedic Sciences
1999-2005: Cell Biology (part signal Transduction): 1st yr Medicine, Biomedical Sciences
2005-present: Biochemistry: 1st yr Biochemistry, Chemistry, Biology, Bioengineers, Pharmacy
Since 2003: promotor 7 PhD thesisses, 5 in preparation

Professor,Departments of Social and Behavioral Sciences and Epidemiology, School of Global Public Health, New York University
Honors/Awards
Ranked in top 5% of investigators for receipt of NIH funding over the past 25 years
ISI identified ―Highly Cited Author‖
Visiting Distinguished Professor, Department of Psychology, University of Spain,
Granada, July 2007.
Prevention Pioneer Award in HIV/AIDS from the Morehouse School of Medicine and the Georgia
Department of Community Health, Office of Minority Health, February 24, 2005
McAuley Lecture for 2003, Georgetown University, November 3, 2003.
Great Teachers Lecture, February 17, 2000, Emory University
Recipient of the 1999 Society for Adolescent Medicine/Organon Pharmaceutical Visiting
Professorship in Adolescent Research
Ira Hiscock Lecturer for 1996. The University of Hawaii, School of Public Health, Oahu, HI,
October 29, 1996
Robert S. Rixse Memorial Lecturer for 1996. Children's National Medical Center, Washington, DC,
June 4, 1996
Kroeber Anthropological Society Plenary Address, March 7, 1987, University of California,
Berkeley, CA 

Director Cardiac Surgery ICU, Onassis Cardiac Surgery Center
Medical Internist-Intensivist
Co-Director, ECMO referral Center (ELSO)

Associate Professor and biostatistician at The George Washington University School of Nursing
Associate Scientist in the Department of Biostatistics & Medical Informatics and co-director of the Biostatistics and Data Management Unit at the Wisconsin Alzheimer's Disease Research Center (ADRC)

Professor, College of Medicine and Life Sciences, University of Toledo 

2018, Jan-present Associate Professor in pharmacology and therapeutics)  Sapienza University of Rome, Department of Physiology and Pharmacology "Vittorio Erspamer" Rome, Italy
2008-2017 (December) Assistant professor (University Researcher ) in Toxicology  / Clinical trials , pharmacoepidemiology and pharmacovigilance
2012-2013 (January-April) Visiting assistant professor at Beth Israel Deaconess Medical Center, Department of  Neurology Boston, United States
2010 Lecturer of Clinical trials , pharmacoepidemiology and pharmacovigilance
2008 Researcher (Assistant Professor in pharmacology and therapeutics)  Sapienza University of Rome, Department of Physiology and Pharmacology "Vittorio Erspamer" Rome, Italy

MD, doctor of ultrasound in the Department of Peking University Third Hospital. Graduated from Peking University, majoring in imaging medicine and nuclear medicine. Main research interests are: Ultrasound diagnosis and interventional therapy, contrast-enhanced ultrasound and elastography.

Dr Carmine Finelli is currently senior registrar of the Department of Emergency and Internal Medicine, Ospedale S. Maria della Pietà – ASL Napoli 3 Sud, Nola (Naples), Italy. Dr. Finelli obtained his Doctor of Medicine degree in 1999 at the Federico II University Medical School in Naples discussing the thesis: “Prevalence of eating disorders in obese outpatients”. He obtained his PhD in “Clinic and Pathology of Chronic-Degenerative Cardiovascular, Rheumatic and Nutritional diseases” at the Department of Clinical and Experimental Medicine, Federico II University Medical School in Naples in 2004.  Research work was carried at the Clinical Nutrition Unit of the same Department. He also obtained his postgraduate degree in Internal Medicine, in 2008, at the Department of Clinical and Experimental Medicine, Federico II University Medical School in Naples. His main research interests are in polymorphism genetic in severe obesity; indicators of the nutritional status; pathogenetic mechanisms of insulin-resistance, hypertension and fatty liver in obesity; physical activity and energy expenditure in human obesity; metabolic and nutritional status in severely obese patients treated with bariatric surgery at short and long-term. He is also author of more than 124 papers, 46 published on peer-reviewed international journals. Dr. Finelli is currently involved in studies on the physiopathology, genetic and treatment of obesity. 

Dr Carmine Finelli is currently senior registrar of the Department of Emergency and Internal Medicine, Ospedale S. Maria della Pietà – ASL Napoli 3 Sud, Nola (Naples), Italy. Dr. Finelli obtained his Doctor of Medicine degree in 1999 at the Federico II University Medical School in Naples discussing the thesis: “Prevalence of eating disorders in obese outpatients”. He obtained his PhD in “Clinic and Pathology of Chronic-Degenerative Cardiovascular, Rheumatic and Nutritional diseases” at the Department of Clinical and Experimental Medicine, Federico II University Medical School in Naples in 2004.  Research work was carried at the Clinical Nutrition Unit of the same Department. He also obtained his postgraduate degree in Internal Medicine, in 2008, at the Department of Clinical and Experimental Medicine, Federico II University Medical School in Naples. His main research interests are in polymorphism genetic in severe obesity; indicators of the nutritional status; pathogenetic mechanisms of insulin-resistance, hypertension and fatty liver in obesity; physical activity and energy expenditure in human obesity; metabolic and nutritional status in severely obese patients treated with bariatric surgery at short and long-term. He is also author of more than 124 papers, 46 published on peer-reviewed international journals. Dr. Finelli is currently involved in studies on the physiopathology, genetic and treatment of obesity. 

Marco Fiore is a Researcher at IBBC-CNR—Institute of Biochemistry and Cell Biology-CNR. He completed his Ph.D. studies in Medical Sciences at the University of Groningen in 2004. He has published 39 papers, with 5900 citations and an h-index of 50 (Scopus, october 2024). His research topics mainly include oxidative stress, neurobiology, toxicology, and addiction.

 Executive Chairman of the Board, Can-Fite BioPharma, Petah Tiqwa, Israel

Prof. dr Sandrine Florquin, Renal Pathologist, P.I., Department of Pathology, Academic Medical Center, University ofAmsterdam 

Prof. Dr. Eleonore Fröhlich is the Head of Core Facility Microscopy at the Center for Medical Research, Medical University of Graz, Graz, Austria. Besides, she is also a key researcher at the Research Center of Pharmaceutical Engineering, a professor at the Institute of Anatomy, University Tübingen, and a mentor at NORGANOID GmbH. She was awarded the Top 2% cited scientist (field pharmacology and pharmacy), Stanford University Ranking in 2022, and Testing of inhaled nanoparticles in airway tissues (1st prize) in 2021. Her scientific expertise is in histology, microscopy, electron microscopy, cell culture, immunohistochemistry, nanotoxicology, cell-based assays, and inhalation.

MD, PhD, Professor, Molecular pathologist, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Visiting Professor of Haematology, Imperial College London
Honorary Professor, Institute of Hematology, Chinese Academy of Medical Sciences and Peking Union Medical College
Fellow, American College of Physicians
Fellow, Royal College of Physicians; Fellow, Royal Society of Medicine; Fellow, Royal College of Physicians of Ireland
Honorary Member, Russian Academy of Medical Science
Olender Peace Award, 1986 and 2017
Presidential Award, New York Academy of Science, 1986
Scientist of Distinction Award, Weizmann Institute of Science, 1986
Editorial Board of 12 journals, including Editor-in-Chief, Leukemia; Executive Editor, Bone Marrow Transplantation; Associate Editor, Clinical Transplantation
Over 1300 scientific articles and more than 20 books

Professor, Surgery Turku University Hospital, University of Turku, Turku, Finland

Senior Research Specialist, Department of Laboratory Medicine, Karolinska Institutet 

Post-Doc, Sapienza University of Roma 

Director of Unit of Radiation Oncology, Ospedale del Mare, Naples, Italy

Dr. Merete Haedersdal is a dermatologist and associate clinical professor of dermatology at the University of Copenhagen, Denmark. She directs the Laser Dermatology Clinic at Bispebjerg University Hospital in Copenhagen. Currently Dr. Haedersdal is a visiting associate professor at the Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School focusing on “laser-assisted drug delivery” together with Dr. R. Rox Anderson’s team.She received her M.D. degree from the Medical School program of the university of Copenhagen, Denmark and she was authorised as a specialist in dermato-venereology in 2004. Dr. Haedersdal received her Ph.D degree in 1997 and became Dr. of Medical Science in 1999 from university of Copenhagen. Her theses cover different aspects of side effects from dermatological laser procedures in murine and human experiments. Dr. Haedersdal is consultant for the National Board of Health in Denmark and she has actively been involved in the Danish legislation about safety in aesthetic procedures with lasers, IPL systems and related technologies. Her research interests include laser therapy in dermatology, photodynamic therapy, skin cancer, and evidence-based treatments with light-emitting devices.

Prof. Michael Hamblinwas the Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School and is a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology. He was trained as a synthetic organic chemist and received his PhD from Trent University in England. His research interests lie in the areas of photodynamic therapy (PDT) for infections, cancer, and heart disease and photobiomodulation for wound healing, arthritis, traumatic brain injury and hair regrowth. He directed a laboratory of sixteen post-doctoral fellows, visiting scientists and graduate students. His research program is supported by NIH, CDMRP, USAFOSR and CIMIT among other funding agencies. He has published over 600 peer-reviewed articles, over 150 conference proceedings, book chapters and international abstracts and holds 8 patents. He has authored/edited 23 textbooks on PDT and photomedicine including SPIE proceedings. He is Associate Editor for 10 journals, on the editorial board of a further 25 journals and serves on NIH Study Sections. For the past 10 years Prof Hamblin has chaired an annual conference at SPIE Photonics West entitled “Mechanisms for low level light therapy” and he has edited the 10 proceedings volumes together with four other major textbooks on PDT and photomedicine. He has several other book projects in progress at various stages of completion. Prof Hamblin has received a number of prestigious honours and awards, and in 2011 was honored by election as a Fellow of SPIE. Prof Hamblin has been appointed as a visiting professor at a number of institutions including the Guangxi Medical University, Nanning, China, Laser Research Centre Health Sciences, University of Johannesburg, South Africa, and School of Pharmacy, University of Ulster Coleraine, UK. Prof Michael Hamblin is the world’s the most documented authority on Neuromodulation. He is Editor-in-Chief of “Photobiomodulation, Photomedicine and Laser Surgery”, is Associate Editor for 10 other journals. He has a Scopus H-index of 104 with 44918 citations. He has been on the Clarivate Web of Science list of most highly cited authors for the last 3 years. Dr Hamblin was elected as a Fellow of SPIE in 2011, received 1st Endre Mester Lifetime Achievement Award Photomedicine from NAALT in 2017, and Outstanding Career Award from Dose Response Society in 2018.

Prof. Dr. Alireza Heidari, Ph.D., D.Sc.
Full Distinguished Professor and Academic Tenure of Chemistry 
Enrico Fermi Distinguished Chair in Molecular Spectroscopy
Head of Cancer Research Institute (CRI) 
Director of the BioSpectroscopy Core Research Laboratory (BCRL)
Faculty of Chemistry, California South University (CSU), Irvine, California, USA 
Board Member of the World Association of Theoretical and Computational Chemists (WATOC) 
Continuous Member of the American Association for Cancer Research (AACR), Philadelphia, Pennsylvania, USA 
Continuous Member of the American Society for Biochemistry and Molecular Biology (ASBMB), Rockville, Maryland, USA 
President of the American International Standards Institute (AISI), Irvine, California, USA 

Adjunct Professor, Department of Obstetrics and Gynecology, McGill University   
Medical Director of the McGill University Health Centre (MUHC) Reproductive Centre
Director of the Reproductive Endocrinology and Infertility Division of McGill University in Montreal 
Director of the R.E.I. and I.V.F. Departments
Associate Director of the Division of Obstetrics and Gynecology, at the Hadassah Medical Organization in Israel
Member of provincial ART advisory committees in both Quebec and Ontario

Shareholder & Owner, Innovation Center for Advanced Technology, Matrix HT, Inc. New York, USA

2024.08- Director, School of Nutrition and Health Sciences, Taipei Medical University
2023.07 – 2023.09 Acting Chair, School of Nutrition and Health Sciences, Taipei Medical University
2023.07 – 2023.09 Acting Vice Dean, College of Nutrition, Taipei Medical University
2017- Professor, School of Food Safety, Taipei Medical University
2017- Professor, Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University
2017- Professor, School of Nutrition and Health Sciences, Taipei Medical University
2013-2017 Associate Professor, School of Nutrition and Health Sciences, Taipei Medical University
2012-2013 Assistant Professor, School of Nutrition and Health Sciences, Taipei Medical University
2012-2012 Associate Professor, Kai-Nan University
2009-2012 Assistant Professor, Kai-Nan University
2007-2009 Assistant Professor, Cardinal Tien College of Healthcare and Management
2006-2007 Postdoctoral researcher, National Taiwan University
Awards
2024 Research Dissertation Award - Excellence Award, Taipei Medical University
2019 Research Dissertation Award - Excellence Award, Taipei Medical University
2019 International Top Journal Publication Award, Taipei Medical University

Professor of ophthalmology at New York Medical College and the Icahn School of Medicine at Mount Sinai, as well as the director of the Organ Culture Center at New York Eye and Ear Infirmary.
Hu attended and graduated from the Medical Department of Shanghai First Medical College from 1952 to 1955. After graduation, Hu worked at several institutions including Second Hospital of Shanghai Textile Engineering Bureau, Shanghai Branch of the Chinese Medical Association. In 1979, he became the director of the Zhabei Eye Disease Prevention and Control Institute in Shanghai, holding the position of deputy chief physician.
Hu has served as a research consultant for pharmaceutical companies such as Pfizer, Merck, and Allergan, etc.
Hu major research achievements include the establishment of methods for the isolation and culture of choroidal and conjunctival melanocytes, and iris pigment epithelial cells, as well as the establishment of an eye cell bank. He conducted research on the etiology, epidemiology, and drug treatment of ocular melanoma, and resolved the long-standing debate on the relationship between ocular melanoma and sunlight. He also conducted research on the etiology, pathogenesis, genetics, and epigenetic regulations of myopia and age-related macular degeneration.
In the field of translational medicine, Hu conducted studies on the transplantation of cultured skin melanocytes for the treatment of vitiligo, oral retinoid acid therapy for proliferative vitreoretinopathy, and transplantation of iris pigment epithelial cells for the treatment of retinal diseases.
He has published over 300 papers, including 147 in SCI journals such as Am J Human Genet, Cancer Res, Pigment Cell Melanoma Res, J Med Genet, Ophthalmology, JAMA Ophthalmology, Am J Ophthalmol, Invest Ophthalmol Vis Sci, J Am Acad Dermatol, and Br J Dermatol. He has authored several books on ophthalmic genetics and myopia, and co-authored nine international ophthalmology monographs.
Hu has received numerous research grants and awards, including the 2009 National Science and Technology Progress Award (Second Prize) for clinical research and application of simple myopia prevention. He was also awarded the Outstanding Achievement Award in Ophthalmology and Visual Science for Overseas Chinese by the Chinese Medical Association's Ophthalmology Branch.
He organized the Chinese Genetic Society's Ophthalmic Genetics Group and served as its chairman from 1979 to 1989. He was also involved in the establishment of the Chinese Ophthalmological Society's Ocular Optics Group and served as its executive vice chairman in charge of academics. He organized and chaired 11 international academic conferences on ocular melanocytes and myopia.
Hu has been invited to give academic lectures at institutions such as the National Eye Institute, Harvard University, and Yale University.
He has served as an executive director of the International Society of Ophthalmic Genetics, president of the International Society for Ocular Melanocyte Research, Association.
He has also served as editor-in-chief and editorial board member of several academic journals, including deputy editor-in-chief of Pigment Cell Research and reviewer for important journals such as Proc Natl Acad Sci USA and Ophthalmology.

Dr. Marcello Iriti is an Associate Professor of Plant Biology and Pathology within the Department of Agricultural and Environmental Sciences at the University of Milan.

He has been studying nutraceuticals, functional foods, phytotherapeutics and essential oils relevant for human and animal health, focusing on their preclinical (in vitro/in vivo) and in human pharmacological activities. He has also been investigating the health-promoting effects of traditional Mediterranean diet as well as the ethnopharmacology of herbal remedies of traditional healing systems.

Dr. Iriti is a Member of the World Academy of Sciences, Asian Council of Science Editors and Society of African Journal Editors. Founding Member of the Italian Society of Environmental Medicine. Member of the Working Group ‘Pharmacognosy, Phytotherapy and Nutraceuticals’ of the Italian Pharmacological Society.

Associate Professor of periodontology and oral medicine at the School of Dentistry, University of Catania, Italy. 
Member of the Italian Society of Oral Surgery (SIdCO)
Member of the International Association of Dental Research (IADR) 
Member of the Italian Society of Periodontology (SIdP)

Associate Professor (Sungkyunkwan University, 2023-present)
Assistant Professor (Sungkyunkwan University, 2019-2023)
Postdoctoral Scholar (Stanford University, 2015-2018)
Graduate Researcher (Nanyang Technological University, 2011-2015)
Graduate Researcher (Harvard-MIT, 2010-2011)
Undergraduate Researcher (Stanford University, 2008-2010)
Undergraduate Researcher (University of Florida, 2007-2008)

Professor in the Department of Surgery and the Department of Biochemistry and Biomedical Sciences at McMaster University, and he also holds a professorship at the University of Toronto. Dr. Jeschke’s research focuses on uncovering the challenges that older adult burn patients face and understanding why they often experience poorer outcomes. His work examines how severe burn injuries accelerate biological aging processes by impacting tissue plasticity, immune function, and metabolic resilience. Through studying these age-related declines and the cellular and molecular changes that contribute to them, Dr. Jeschke aims to identify therapeutic targets to enhance recovery and counter the accelerated aging observed in trauma survivors.

Professor in Ophthalmology and Bioengineering Hanna and Mark Gleiberman Chancellor's Endowed Chair in Glaucoma Research

Professor, College of Medicine, Medical University of South Carolina, Charleston, USA

Professor Emeritus, Department of Cardiology, University of Patras Medical School Patras, Greece
Scientific Advisor, Patras State General Hospital, Patras, Greece
Practicing Cardiologist

Head of Hepatology at the Department of Gastroenterology and Hepatology, University Hospital Zurich in Zurich, Switzerland. Professor Kremer is internationally recognized as a clinician, educator and researcher in liver disease. His translational, clinical and experimental research is focused on molecular mechanisms of immune-mediated and cholestatic liver disease including symptom burden such as fatigue and pruritus, fibrogenesis and development of hepatocellular carcinoma. Prof. Kremer has been awarded several national and international research prizes including the Schering-Plough of the Dutch Society of Gastroenterology. His scholarly work has been cited more than 6,500 times (h-index: 42), according to Google Scholar, and he is a member of editorial boards for various journals. He served as a chair for several national and international guidelines, is a member of the Board of Directors of the Swiss Association for the Study of the Liver (SASL) and Chair of International Forum for the Study of Itch special interest group for systemic pruritus.

Professor, Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria

Assistant professor, Erasmus University Medical Center

Assistant Professor, Department of Human Genetics, Emory University, Atlanta, USA

Professor, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China

Professor, The Second Affiliated Hospital of Nanchang University
Chief physician, The Second Affiliated Hospital of Nanchang University

Professor, Faculty of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, Beijing, China
Dircector, Chinese PLA General Hospital (301 Hospital)

Full Professor of Advanced Medical and Surgical Technical Sciences, University of Catania, Italy

Consultant Neurologist & Chief, Clinical Neurophysiology Research Unit, Oasi Research Institute‑IRCCS (a WHO Collaborating Centre), Troina, Italy

Assistant Professor (Senior Academic Researcher), University of Catania

Visiting Clinical Research Fellow, Department of Neuroscience & Clinical Neurophysiology, Newcastle University, UK

Scientific Fellow selected by the European Federation of Neurological Societies (EFNS), 2013

International award for translational research in sleep medicine

Herb and Jean Lyman Centennial Chair in Ophthalmology, Department of Ophthalmology-Blanton Eye Institute
Professor of Ophthalmology, Neurology, and Neurosurgery, Academic Institute
Member, Research Institute, Academic Institute
Chair, Department of Ophthalmology-Blanton Eye Institute
Program Director, Neuro-Ophthalmology Fellowship, Department of Ophthalmology-Blanton Eye Institute

Chair of Department of Pathology, Chi Mei Medical Center
Professor at Southern Taiwan University of Science and Technology
Joint-appointment associate investigator at National Institute of Cancer Research (Taiwan)

Prof. Dr. Jian-Jun Li is a renowned cardiologist at Fu Wai Hospital, Chinese Academy of Medical Science, Beijing. He holds an MD from Wuhan University, a PhD from Kyushu University, Japan, and completed post-doctoral training in the USA. As Professor and Consultant at the Cardiometabolic Center, his research focuses on dyslipidemia, inflammation, atherosclerosis, and interventional cardiology. He serves as Vice President of the Chinese Molecular College of Cardiology and is a national expert in cardiovascular disease prevention. Prof. Li has received multiple prestigious science awards, recognizing his significant contributions to cardiovascular medicine and public health in China.

Associate Professor in Department of Neurological Surgery at Rush University, Chicago, USA. He has a number of research interests, and his brain tumor work is largely focused on the development of a DNA vaccine for treatment of primary and metastatic intracerebral tumors. In particular Dr. Lichtor has shown that vaccines prepared by transfer of DNA from the tumor into a highly immunogenic cell line stimulates an antitumor immune response which may be efficacious in the treatment of patients with brain tumors. Other research interests include developing a passive immunotherapeutic strategy for treatment of Alzheimer’s Disease. In addition, he has been involved in the development of a non-invasive MRI technique to measure intracranial pressure and brain compliance, and has been exploring the efficacy of this modality in managing a variety of patients with neurologic problems where intracranial pressure is an issue. Dr. Lichtor is a member of the neurosurgery faculty at Rush University Medical Center in Chicago, Illinois.

Ton Lisman is a biochemist with a profound interest in translational clinical research. He received his PhD at the Department of Hematology from the University Medical Center Utrecht in The Netherlands on a thesis on the mechanism of action of recombinant coagulation factor VIIa in 2002. Since 2007, he works at the Surgical Research Laboratory and the Section of Hepatobiliary Surgery and Liver Transplantation at the Department of Surgery of the University of Groningen in The Netherlands. He was appointed full professor of Experimental Surgery in 2015. He serves as co-Editor in Chief for the Journal of Thrombosis and Hemostasis and leads the ISTH/SSC subcommittee on “Hemostatic management of patients with liver diseases”. His research interests include hemostatic changes in liver disease and liver surgery, the role of hemostatic components in damage and repair of liver tissue, and the role of the fibrinolytic system in thrombosis. These topics are studied in close collaboration with local and international clinical partners, which include surgeons, hepatologists, hematologists, intensivists, and anethesiologists.

Professor in the Department of Microbiology, Immunology and Biopharmaceuticals at National Chiayi University, Taiwan

Professor, Department of Paediatrics, Willem-Alexander Children’s Hospital, Leiden University Medical Center
Head, Department of Paediatrics, Willem-Alexander Children’s Hospital, Leiden University Medical Center

Professor,  Institute of Pharmaceutics, School of Pharmaceutical science, Shandong University

Raimundas Lunevicius, MD, PhD, DSc, FRCS, Professor, is a Consultant in Emergency General and Trauma Surgery at Aintree Hospital, NHS University Hospitals of Liverpool Group, UK, with extensive experience in biliary, gastrointestinal, abdominal wall, visceral trauma surgery, research, clinical audits, education, supervision, medical appraisal, academic editing, and review. He has completed three fellowship programmes: Monbushou (Nagoya University & Aichi Cancer Centre, Japan, 1998–2000), Fulbright–Humphrey (Johns Hopkins University, Bloomberg School of Public Health, US, 2008–2009), and King’s College Hospital (2010–2012). His publications (h-index 78) include 263 refereed articles (PubMed 167), three monographs, seven book chapters, and three edited books (by 15–06–2025). He is the Editor-in-Chief of ‘Emergency Care and Medicine’ (MDPI, Switzerland) and a senior GBD Network collaborator (USA).

Recipient of the National Science Fund for Distinguished Young Scholars
Second-level professor at the School of Medicine, Shanghai Jiao Tong University
Executive director of Gastroenterology and director of Infectious Diseases at Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Deputy director of Shanghai Institute of Digestive Disease
Member of the International Autoimmune Hepatitis Group
Member of the Global Primary Biliary Cholangitis Organization
Member and deputy secretary-general of the Liver Diseases Branch of the Chinese Medical Association
Standing member of the Liver Diseases Professional Committee of the Chinese Research Hospital Association
Deputy chairman of the Liver Diseases Specialty Committee of Shanghai Medical Association
Expert member of the Quality Control Center for Infectious Diseases in Shanghai
Member of the Infectious Diseases Branch of Shanghai Association of Chinese Medicine
Member of the Shanghai Clinical Research Academic Committee, editor-in-chief of International Journal Of Cardiovascular Disease
Deputy editor-in-chief of Gastroenterology
Deputy editor-in-chief of the international academic journal Journal of Gastroenterology & Hepatology.

Head of Department of Histology and Embryology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

Dr. Georgios Antonios Margonis is a senior scientist affiliated with the Department of Surgery at the Memorial Sloan Kettering Cancer Center (MSKCC) and the Operations Research Center of the Massachusetts Institute of Technology (MIT). He earned his MD and PhD degrees from the University of Athens before relocating to the United States in 2014. Since then, he has held positions at Harvard University and the Johns Hopkins University before joining MSKCC. His clinical and research interests encompass hepato–pancreato–biliary diseases and soft tissue sarcomas, with a particular focus on the utilization of biomarkers to inform surgical or medical interventions. More recently, his research has delved into the intersection of artificial intelligence and oncology. Dr. Margonis has authored or co-authored more than 170 papers and has received several national and international awards. Notable awards he has received include the IHPBA Kenneth Warren Award and the Johns Hopkins University Paul Ehrlich Award for outstanding research achievements. He also serves as a reviewer for over 70 journals including The Lancet, JAMA, and Annals of Surgery.

Dr. Martinez-Sobrido is continuing his work with the New York Influenza Center of Excellence, which is part of the National Institute of Allergy and Infectious Diseases Centers of Excellence for Influenza Research and Surveillance (CEIRS) program through the National Institutes of Health. In addition to characterizing the influenza virus, as part of this project, he is working with collaborators to develop a universal flu vaccine with the use of broadly neutralizing antibodies (bNAbs) or blood proteins that can recognize key pieces of the virus to help a person’s immune system clear infected cells from the system. Studies are underway to test these bNAbs in small animal models and suitable candidates will move into nonhuman primate models.

Associate Professor, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Professor, Department of Physiotherapy, University of Valencia, Valencia, Spain

Professor, Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba
Scientist, Children's Hospital Research Institute of Manitoba

Prof. Dr. Enrico Mastrobattista is a Professor of Pharmaceutical Biotechnology & Delivery at the Utrecht University. He obtained his Ph.D. in Advanced Drug Delivery from Utrecht University in 2001 and worked from 2001-2004 as a Marie Curie postdoctoral fellow at the MRC-Laboratory of Molecular Biology in Cambridge (UK). In 2013 he was awarded the Prestigious Galien Research Price, The Netherlands, for his research on drug delivery. In addition, he is a board member of the Netherlands Society of Gene & Cell Therapy. His main areas of expertise are drug delivery, pharmaceutical biotechnology and nanobiotechnology with a focus on the intracellular delivery of nucleic acids, CRISPR-Cas gene editing components and genetic vaccines. He has published over 140 articles in scientific journals, contributed to several book chapters in pharmaceutical biotechnology and holds several patents to his name.

Professor of Gastroenterology at the University of Leicester 
Director of the Leicester Complementary Therapy Centre. 

Professor of Pathology, Microbiology and Immunology, School of Medicine, Vanderbilt University, Nashville, USA

Professor of Musculoskeletal Biology in the Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Finland
Chief Researcher and International Adviser at the State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania
Previously President of the Osteoarthritis Research Society International (OARSI)
Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Scientific Collaborator at the Université de Liège
Active member of OARSI and the International Cartilage Regeneration & Joint Preservation Society (ICRS), serves on the Translational Science Committee.
Editorial Board of Osteoarthritis and Cartilage (Elsevier)
Editorial Boards of Osteoarthritis and Cartilage Open (Elsevier) and Osteoarthritis Imaging (Elsevier) and Scientific Reports (Springer Nature).
Published over 400 scientific articles, h-index: 78 (Scopus)

Associate professor of Experimental Cardiac Surgery at University of UKSH-Campus Luebeck in Germany

Adjunct Clinical Associate Professor of Surgery, Indiana University School of Medicine and Indiana University-Purdue University
Adjunct Associate Research Professor, Indiana University School of Medicine and Indiana University-Purdue University
Director, 3D Tissue Bioprinting Core at VA Medical Center

Professor, Baylor College of Medicine, Texas Children's Hospital
Managing Director at Baylor College of Medicine, Texas Children's Hospital

Giuseppe Murdaca has received his PhD in Science and Space Engineering at the University of Genova (Italy) during the period of 2000-2003. Currently, he is working as Assistant professor in Internal Medicine University of Genova (Italy).

His research has included Immunodeficiency Autoimmunity Neuro-endocrino-immunology Pharmacogenomics.

Based on this research and fellowship training he has received several awards and honors, such as:
Prize for young researchers of the study, assigned by the GILS, with the following motivation: "Standardization of a method to assess impairment by skinfold thickness skin", delivered on the occasion of the "Day VII Italian to fight Scleroderma" (Milan, 17/3 / 2001).

Award for one of the three best oral presentations at the Ninth Congress of the Inter-SIMI Piemonte and Valle D'Aosta, Liguria (Genoa, 06.17.2004): Murdaca G., Fenoglio D., M. Setti, Brenci S., Villa R., Pontali E., A. Kunkl, Indiveri F., Puppo F. "Generation of CD4 + lines specific for Pneumocystis carinii and Candida albicans obtained from HIV + patients. Meaning of the coexpression of IFN-? and IL-4 ".

Associate Professor of restorative dentistry at A.T. Still University’s Missouri School of Dentistry & Oral Health (ATSU-MOSDOH)
Assistant Dean, Preclinical Education and Simulation Clinic, Missouri School of Dentistry & Oral Health, A.T. Still University, Kirksville 

Professor, Department of Biomedical Sciences, Noorda College of Osteopathic Medicine, Provo, UT-USA
Adjunct professor, Roseman University of Health Sciences
The chief objectives of his lab investigations are to examine the involvement of cellular metabolism and oxidative stress signals in inflammation. He uses various genetic, biochemical and cell biological approaches to analyze inflammatory responses regulated by cellular lipid metabolites leading to secondary diabetic complications and cancer. He has published more than 140 peer reviewed articles. He is also serving as an editorial board member of several journals.   

Dr. Srivastava has served as a professor and eminent scientist in major US Universities. He has been proclaimed as an eminent scholar by the Kansas Bioscience Authority, and endowed professor at KUMED. The list of accolades and awards conferred on him is huge and rightly deserved too as he has been a pioneer in some trailblazing subjects when it comes to research. He has received national merit awards and scholarships during his graduate and postgraduate studies. He was awarded fellowships at the National Institutes of Health, and the National Academy of Sciences, USA, and a Career Development Award from the US Army. Furthermore, he has been rightly touted as a Scholar by Louisiana Cancer Research Consortium.

Sathish Thirunavukkarasu is an Assistant Professor at the Department of Family and Preventive Medicine, Emory School of Medicine. Sathish completed his Medical Degree, Diploma in Family Medicine, and Master's Degree in Public Health in India and received a PhD in Diabetes Epidemiology from the University of Melbourne in Australia. After his PhD, he did two years of Postdoctoral training at Nanyang Technological University in Singapore and three more years at McMaster University in Canada.

His primary research focuses on the epidemiology of type 2 diabetes and its prevention by developing novel interventions. He is also keen on translating the evidence from research into clinical and public health practice. Sathish has published research articles in very high-impact, leading medical and global health journals such as Nature Reviews Endocrinology, The Lancet Diabetes & Endocrinology, The Lancet Global Health, Diabetes Care, and PLoS Medicine as the lead author.

Specialized in Obstetrics and Gynecology at the University Medical School of Bari. Professional Training in Gynecological Laparoscopy at the Center for Advanced Pelvic Surgery and National Center for Endometriosis (European Gynecologic Endoscopic School), Malzoni Medical Center, Avellino, Italy, directed by Dr Mario Malzoni. National Authorirization as Associate Professor in Obstetrics and Gynecology.

President of the World Institute of Pain President, Paolo Procacci Foundation General Manager, ASL Teramo, Public Company of the National Health Care Service President of the European Pain Federation (EFIC) President of Clinicians Council, UNIVAQ Full Professor, Anesthesia and Pain Medicine, UNIVAQ Assoc. Professor of Anesthesia and Pain Medicine, UNIVAQ Chairman, Dept. of Anesthesia, UNIVAQ Invited Professor, Dept. of Anesthesia, University of Barcelona, Spain Invited Professor, Dept. of Anesthesia, University of Massachusetts, Worchester, MA, USA; and University of Tel-Aviv, Israel Assist. Professor of Anesthesia and Pain Medicine, UNIVAQ, L’Aquila, Italy Researcher, University of Roma, Italy Researcher, University of Hamburg, Germany Researcher CNR-NIH, Albert Einstein College of Medicine, Yeshiva University, New York, NY, USA

Dr. Pavlos Zarogoulidis, M.D, Ph. D Director of Pulmonary Department, ``General Clinic Euromedica`` Private Hospital, Thessaloniki, Greece have three MS.c in ``Clinical Pharmacology``, ``Sleep Medicine`` and  ``Thyroid Gland Disease and Treatment ``and my Ph. D is regarding inhaled chemotherapy for lung cancer. In my everyday practice I perform diagnosis for lung cancer with bronchoscopy, radial and convex probe endobronchial ultrasound and medical thoracoscopy. 

Professor Zhu Pingping has studied the microenvironmental regulation and epigenetic regulation of long-term stem cells (adult stem cells and tumor stem cells), identified multiple stemness regulatory factors and regulatory pathways of tumor stem cells and intestinal stem cells, and discovered a new model of immune microenvironment regulation of intestinal stem cells. Professor Zhu Pingping has successively presided over the China Association for Science and Technology Young Talent Support Project, the Postdoctoral Innovation Talent Support Program, the National Natural Science Foundation of China General Project, and the Excellent Youth Project. He has published more than ten papers as the first author or general author in journals such as Nat Immunol, Nat Cell Biol, Nat Struct Mol Biol, J Clin Invest and Nat Commun, and has published more than 30 SCI articles in total, with a total impact factor of more than 300 and a citation rate of more than 1,000 times in two years. He has won the Special Award of the President of the Chinese Academy of Sciences and the First Prize of Beijing Science and Technology Progress.

Dutch and European Patent Attorney, UPC Representative
Scientist, Amsterdam University Medical Center, Netherlands, 2007-2016.